Biological Activity: Measured by its ability to inhibit IL-13-dependent proliferation of TF-1 human erythroleukemic cells. The ED50 for this effect is 0.690 µg/mL in the presence of 4 ng/mL rmIL-13, corresponding to a specific activity is 1.449×103 units/mg.